Marksans Pharma Ltd. — AGM Information 2018

Sep 27, 2018

·4· Marksans Pharma Ltd.

BSElimited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (EastL Mumbai - 400051. Symbol: MARKSANS

Dear Sirs,

Sub: Proceedings of the 26[th] Annual General Meeting of Marksans Pharma limited held on Thursday, September 27, 2018.

This is to inform you that the 26[t][h] Annual General Meeting (IiAGM[Ii] ) of Marksans Pharma Limited (lithe Companyli) was held on Thursday, September 27, 2018 and the business mentioned in the Notice dated August 25, 2018 was transacted.

Summary of proceedings under Regulation 30, Part-A of Schedule-III of SEBI (Listing Obligations ~nd Disclosure Requirements) Regulations, 2015 is given below:

1. Date, Time and Venue of the Meeting:

The AGM of the Members of the Company was held on Thursday, September 27, 2018 at 10:30 a.m. at GMS Banquet, Next to D. N Nagar Metro Station, Opp. Indian Oil Nagar, New Link Road, Andheri (West), Mumbai - 400053. The meeting concluded at 11:35 a.m. on the same day.

1. Brief details of the items deliberated at the meeting and the results thereof:

2. a. Mr. Mark Saldanha, Chairman chaired the proceedings of the meeting.

3. d. The following items of Ordinary and Special business as per the Notice of AGM dated August 25, 2018, were transacted at the meeting:

   • Consideration and adoption of the Standalone and Consolidated Audited Financial Statements of the Company for the financial year ended 31[s][t] March, 2018 together with the reports of the Board of Directors' and the Auditors' thereon.

   • Dec"laration of dividend of Rs. 0.05 (i.e. 5%) on Equity Shares of Re. 1/- each face • value and dividend of Rs. 7.00 (i.e. 7%) on Redeemable Cumulative Preference Shares of Rs. 100/- each face value for the financial year!.ended www.mark March 31, sanspharma.com 2018.

CIN : L24110MH1992PLC066364

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony. Veera Desai Extension Road. Oshiwara, Andheri (W). Mumbai - 400 053 • Tel.: +91 224001 2000 • Fax: +91-224001 2011 E-mail: info@marksanspharma.com

==> picture [226 x 70] intentionally omitted <==

----- Start of picture text -----

·t·
Marksans Pharma Ltd.
----- End of picture text -----

• Re-appointment of Dr. Vinay Gopal Nayak (DIN: 02577389), who retired by rotation and being eligible, offered himself for re-appointment.

• Appointment of Mis Bhuta Shah & Co. LLP as Statutory Auditor to fill casual vacancy.

• Extension of redemption period of 7% Redeemable Cumulative Preference Shares of Rs. 100/- each.

• Appointment of Mr. Digant Mahesh Parikh (DIN: 00212589) as an Independent Director of the Company.

• Approval of Marksans Employees Stock Option Scheme 2018.

• e. Clarifications were provided to the queries raised by the members at the meeting.

• f. The Chairman informed the members that Ms. Khushboo Bakul Gopani, Practicing Company Secretary was appointed as Scrutinizer for the purpose of scrutinizing the remote e-voting process and voting through ballot paper at the venue of the AGM in a fair and transparent manner.

• g. The Chairman further informed that results of voting shall be announced by Saturday, 29[th] September, 2018 by intimation to the Stock Exchanges and would also be placed on the website of the Company www.marksanspharma.com.

3. Manner of approval:

• Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the Listing Regulations, the Company had provided remote e-voting facility to its members to cast votes electronically, on all the resolutions set out in the notice.

• Further, the facility for voting through ballot was also made available to the members who were present at the AGM and had not cast their votes by remote e-voting.

Yours faithfully,

For Marksans Pharma Limited

Harshavardhan Panigrahi Company Secretary & Manager-Legal

www.marksanspharma.com